Evidence map›Paper›PMID 25640580›Full record

Trial reportJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2015

Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status.

Anne L Schafer, Connie M Weaver, Dennis M Black, Amber L Wheeler, Hanling Chang, Gina V Szefc, Lygia Stewart, Stanley J Rogers, Jonathan T Carter, Andrew M Posselt and 2 more

3 registry-linked trialsOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 83 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 5 pooled it
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01330914 completednot on this map

Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton

TypeobservationalSponsorVA Office of Research and DevelopmentRan2011 to 2015Enrolled55ConditionsObesity, Morbid, Gastric Bypass
NCT04742010 phase2completednot on this mapstarted 2021, after this paper: background citation

Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)

TypeinterventionalSponsorStinus Gadegaard HansenRan2021 to 2024Enrolled59ConditionsBone Loss, Muscle Atrophy, Bariatric SurgeryArmsZoledronic Acid, Placebo
NCT06042985 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

Comparison of the Absorption of Calcium Citrate and Calcium Carbonate in Patients With an RYGB, LSG, and OAGB A Double-blind, Randomized Cross-over Trial

TypeinterventionalSponsorGeneral Committee of Teaching Hospitals and Institutes, EgyptRan2023 to 2024Enrolled150ConditionsCalcium Citrate Absorption, Calcium Carbonate AbsorptionArmsThe absorption effect between calcium citrate and calcium carbonate
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 5 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Two-year changes in bone density after Roux-en-Y gastric bypass surgery.The Journal of clinical endocrinology and metabolism · 2015
    Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Observational
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Anne L SchaferMedical Service, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Connie M WeaverDepartment of Nutrition Science, Purdue University, West Lafayette, IN, USA.
Dennis M BlackDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Amber L WheelerMedical Service, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Hanling ChangMedical Service, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Gina V SzefcMedical Service, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Lygia StewartDepartment of Surgery, University of California, San Francisco, CA, USA.
Stanley J RogersDepartment of Surgery, University of California, San Francisco, CA, USA.
Jonathan T CarterDepartment of Surgery, University of California, San Francisco, CA, USA.
Andrew M PosseltDepartment of Surgery, University of California, San Francisco, CA, USA.
Dolores M ShobackMedical Service, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Deborah E SellmeyerDepartment of Medicine, The Johns Hopkins University, Baltimore, MD, USA.
University of California, San Francisco · USSan Francisco VA Medical Center · USJohns Hopkins Medicine · USPurdue University West Lafayette · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAISSE, CHRISTIAN · 2003 to 2019
$21.8M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
DIABETES, ENDOCRINOLOGY &METABOLISM TRAINING PROGRAMT32DK007418 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARD C HSIAO · 1986 to 2026
$14.3M
Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
UCSF/Kaiser-DOR Program for Developing Independent Women's Health ResearchersK12HD052163 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ADLER, NANCY E, BRINDIS, CLAIRE D. · 2005 to 2023
$9.3M
UCSF Core Center for Musculoskeletal Biology and MedicineP30AR066262 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MAJUMDAR, SHARMILA · 2014 to 2018
$3.0M
Effects of Gastric Bypass Surgery on Calcium Metabolism and the SkeletonIK2CX000549 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI SCHAFER, ANNE LOUISE · 2011 to 2015
–
CSRD VA IK2 CX000549Intramural VA VA999999NCATS NIH HHS KL2 TR000143NCATS NIH HHS UL1 TR000004NIAMS NIH HHS P30 AR066262NICHD NIH HHS 5 K12 HD052163-15NICHD NIH HHS K12 HD052163NIDDK NIH HHS P30 DK063720NIDDK NIH HHS P30 DK098722NIDDK NIH HHS T32 DK007418
6 · The paper itself

Abstract

Roux-en-Y gastric bypass (RYGB) surgery has negative effects on bone, mediated in part by effects on nutrient absorption. Not only can RYGB result in vitamin D malabsorption, but the bypassed duodenum and proximal jejunum are also the predominant sites of active, transcellular, 1,25(OH)2 D-mediated calcium (Ca) uptake. However, Ca absorption occurs throughout the intestine, and those who undergo RYGB might maintain sufficient Ca absorption, particularly if vitamin D status and Ca intake are robust. We determined the effects of RYGB on intestinal fractional Ca absorption (FCA) while maintaining ample 25OHD levels (goal ≥30 ng/mL) and Ca intake (1200 mg daily) in a prospective cohort of 33 obese adults (BMI 44.7 ± 7.4 kg/m(2)). FCA was measured preoperatively and 6 months postoperatively with a dual stable isotope method. Other measures included calciotropic hormones, bone turnover markers, and BMD by DXA and QCT. Mean 6-month weight loss was 32.5 ± 8.4 kg (25.8% ± 5.2% of preoperative weight). FCA decreased from 32.7% ± 14.0% preoperatively to 6.9% ± 3.8% postoperatively (p < 0.0001), despite median (interquartile range) 25OHD levels of 41.0 (33.1 to 48.5) and 36.5 (28.8 to 40.4) ng/mL, respectively. Consistent with the FCA decline, 24-hour urinary Ca decreased, PTH increased, and 1,25(OH)2 D increased (p ≤ 0.02). Bone turnover markers increased markedly, areal BMD decreased at the proximal femur, and volumetric BMD decreased at the spine (p < 0.001). Those with lower postoperative FCA had greater increases in serum CTx (ρ = -0.43, p = 0.01). Declines in FCA and BMD were not correlated over the 6 months. In conclusion, FCA decreased dramatically after RYGB, even with most 25OHD levels ≥30 ng/mL and with recommended Ca intake. RYGB patients may need high Ca intake to prevent perturbations in Ca homeostasis, although the approach to Ca supplementation needs further study. Decline in FCA could contribute to the decline in BMD after RYGB, and strategies to avoid long-term skeletal consequences should be investigated.

Indexed as

Bone RemodelingGastric BypassIntestinal AbsorptionAdultAgedCalciumFemaleHumansMaleMiddle AgedVitamin D25-hydroxyvitamin DCalciumVitamin DBARIATRIC SURGERYBIOCHEMICAL MARKERS OF BONE TURNOVERCALCIUM ABSORPTIONGASTRIC BYPASS SURGERYNUTRITIONVITAMIN D

Identifiers

PMID25640580
PMCPMC4593653
OpenAlexW1973498853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.